Publication date: Available online 15 September 2026 Source: Travel Medicine and Infectious Disease Author(s): Alfonso J. Rodriguez-Morales, Luis Felipe Bambague-Trujillo
Clinical trials in travel medicine: Building evidence, expanding equity, and shaping the future. // Travel Medicine and Infectious Disease. – URL: https://www.sciencedirect.com/science/article/pii/S147789392600075X?dgcid=rss_sd_all
Clinical trials in travel medicine: Building evidence, expanding equity, and shaping the future. Travel Medicine and Infectious Disease. https://www.sciencedirect.com/science/article/pii/S147789392600075X?dgcid=rss_sd_all
“Clinical trials in travel medicine: Building evidence, expanding equity, and shaping the future.” Travel Medicine and Infectious Disease.
@article{article70375,
title = {Clinical trials in travel medicine: Building evidence, expanding equity, and shaping the future},
journal = {Travel Medicine and Infectious Disease},
url = {https://www.sciencedirect.com/science/article/pii/S147789392600075X?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...